• Since the inception of the program, Cleveland Clinic Abu Dhabi has graduated 68 medical interns and 16 residents.
• Cleveland Clinic Abu Dhabi is commitment to developing the next generation of healthcare professionals and positively contributing to the workforce in the region.

Abu Dhabi, United Arab Emirates. October 17, 2024: Cleveland Clinic Abu Dhabi, part of the M42 network, proudly hosted a graduation ceremony for its 2024 cohort of medical residents and interns, celebrating the achievements of 22 graduates from its established Residency and Internship Programs. Among the graduates, 20 are UAE nationals, aligning with the national objective of nurturing local medical talent in healthcare and reinforcing the hospital’s ongoing commitment to advancing healthcare in the country through its medical education programs.

At the ceremony, the graduates were reminded of the impact of their talent and skills to the local and regional medical community, where expertise in advanced and complex care is in high demand. They were encouraged to continue their specialization in top-tier institutions globally or to join leading hospitals within the UAE, contributing to the enhancement of world-class patient care in the region.

Dr. Sawsan Abdel-Razig, Chief Academic Officer at Cleveland Clinic Abu Dhabi, commented on the institution’s dedication to medical education, stating: “Medical education is a fundamental part of our mission at Cleveland Clinic Abu Dhabi. By training the next generation of healthcare professionals, we are building a skilled workforce capable of meeting the growing healthcare needs of the UAE. Our residency program equips young physicians with the knowledge and experience needed to deliver world-class care, bringing advanced healthcare closer to home. We are proud to contribute to the nation’s healthcare landscape and help shape its future.”

Maitha Almazrouei, an Emergency Medicine resident graduate, said: “I joined this program back in 2020, and the most rewarding part of my residency has been the opportunity to make a significant difference in patients’ lives. Working at Cleveland Clinic Abu Dhabi, I’ve seen firsthand the impact of our care on patients and their families, which has reinforced my passion for my profession and commitment to patient-centered care. I have learned a lot throughout my residency, and I look forward to continuing to enhance patient care in the UAE.”

This year, 43 new trainees joined the residency and fellowship programs, achieving an impressive Emiratization rate of 84%, highlighting Cleveland Clinic Abu Dhabi’s commitment to developing the local medical community. Since the inception of the program, Cleveland Clinic Abu Dhabi has graduated 68 medical interns and 16 residents, playing an important role in developing the next generation of healthcare professionals and positively contributing to the workforce in the region.

ENDS

About Cleveland Clinic Abu Dhabi
Cleveland Clinic Abu Dhabi, part of the M42 group, is a multispecialty hospital on Al Maryah Island in Abu Dhabi, UAE. Cleveland Clinic Abu Dhabi is a unique and unparalleled extension of US-based Cleveland Clinic’s model of care, specifically designed to address a range of complex and critical care requirements unique to the Abu Dhabi population. Cleveland Clinic Abu Dhabi has the following Institutes and Departments: Heart, Vascular & Thoracic, Neurology, Digestive Disease, Eye, Respiratory, Critical Care, Oncology, Transplant, Surgical Subspecialties, Medical Subspecialties, Emergency Medicine, Anesthesiology, Pathology & Laboratory Medicine, Imaging, Quality & Patient Safety, Clinical & Nursing, Research and Education Departments. In all, more than 50 medical and surgical specialties are offered at Cleveland Clinic Abu Dhabi.

The campus is also home to a stand-alone and dedicated cancer center, Fatima bint Mubarak Center. The state-of-the-art, facility provides patients with access to diagnostics and treatment options through world- class facilities across 24 clinical departments that include a range of cancer subspecialties and programs: Blood Cancers, Breast Cancers, Endocrine Cancers, Gastrointestinal Cancers, Genitourinary Cancers, Gynecological Cancers, Head and Neck Cancers, Neurological Cancers, Thoracic Cancers, Ophthalmological Cancers and Soft Tissue Cancers among others.

Cleveland Clinic Abu Dhabi provides patients in the region with direct access to the world’s best healthcare providers and Cleveland Clinic’s unique model of care that includes state-of-the-art amenities and world- class service standards closer to home. M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement.

Visit us at www.clevelandclinicabudhabi.ae

• The holistic program underscores commitment to cancer awareness, prevention and treatment across facilities
• Initiatives include screening events, talks, live Q&As and more across communities in UAE

Abu Dhabi, UAE – 17 October 2024 – M42, the tech-enabled global health powerhouse, is running a comprehensive program of initiatives across its world-class healthcare facilities in line with Breast Cancer Awareness Month 2024. The program aims to increase awareness for early detection and regular checkups and highlight the treatments and facilities available for breast cancer, as well as encourage a culture of support for families affected by the disease. Initiatives in the program include community-based awareness talks, live Q&As, lectures and webinars, free mammograms and promotional offers. Traditional pink ribbons are also being distributed to staff and patients to ensure everyone is aware of the significance of the month.

Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42 and Chairman of Cleveland Clinic Abu Dhabi, said: “We join in solidarity with our peers in the medical field across the globe in participating in Breast Cancer Awareness Month. Despite tremendous advances in detection, prevention and treatment, breast cancer still affects millions of women and their families around the world. It is imperative we keep the spotlight firmly on the disease. Education and awareness play a pivotal role in the ongoing fight against breast cancer, and in sharing our program of initiatives across our facilities, we aim to reach as many of our communities as possible.”

M42 is advancing its genomic capabilities and transforming breast cancer treatment by offering tailored insights and interventions. Cleveland Clinic Abu Dhabi (CCAD), part of the M42 group, is at the forefront of integrating whole genome sequencing (WGS) as part of the Emirati Genome Program (EGP), into breast cancer care, identifying individuals at high risk, such as those with specific gene mutations. CCAD’s Hereditary High-Risk Program provides personalized care, monitoring and prevention strategies. Meanwhile, Mubadala Health Dubai is raising awareness through educational lectures led by newly joined ob-gyn doctors in corporate and community settings Danat Al Emarat Hospital for Women & Children is also actively promoting breast cancer awareness by sponsoring Gulf Multi-Sport events like the Zayed Sports City Pink Run and the recently successful Yas Mall Pink Run. The hospital conducted breast health awareness talks at KidZania and Mubadala in early October. HealthPlus Family Centers are similarly engaged, with talks scheduled at Jawaher Al Saadiyat and Saadiyat Beach Residence Communities, focusing on the importance of early detection. HealthPlus is also organizing live and virtual sessions with medical experts, pending their availability.

By engaging communities through a diverse array of initiatives — from screenings to educational talks and cutting-edge genomic insights — M42 aims to empower individuals with the knowledge and resources they need to take proactive steps in their health journeys. Through these initiatives, M42 reinforces its commitment to shaping a future where personalized healthcare and innovative solutions play a pivotal role in the fight against breast cancer.

-ENDS-

About M42
M42 is a first-of-its-kind, global tech-enabled health powerhouse committed to the sustainable future of health. The Abu Dhabi-headquartered company is transforming lives through innovative solutions that are solving the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is delivering the highest level of personalized, precise, and preventative health solutions to impactfully disrupt the global health landscape.

M42 has over 20,000 employees and more than 450 facilities in 26 countries. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 combines leading health technologies with state-of-the-art healthcare facilities to deliver world-class health solutions, services and care.

The M42 group includes Diaverum, Cleveland Clinic Abu Dhabi, Imperial College London Diabetes Centre and Moorfields Eye Hospital Abu Dhabi, among others.

Speaking at GITEX Global, Albarah Elkhani, Senior Vice President Operations, M42 said, “At M42, we deliver quality healthcare for the community through technology and AI-enabled services.”

“Our aim is to support the reduction of healthcare expenses which is extremely imbalanced in line with the GDP. This drives the need for a sustainable healthcare solution,” he explains.

He emphasizes how AI can contribute to cost reduction and drive better outcomes: “AI enables personalized care, reducing the burden of disease and shift toward predictive, preventive and precision medicine.”

Highlighting M42’s flagship LLM model, he says, “Med42, a large language model, that allows the integration of data sets for insights. We collate a significant amount of data at M42 that facilitate a personalized patient journey through our population genome program and personalized medicine approach by integrating the data sets and pulling insights using AI advanced tools.”

On M42’s reach, he notes, “We work across Abu Dhabi, the broader region and globally.” He also explains AI’s role in clinical care: “AI helps us analyze petabytes of data — tasks that are humanly impractical —making insights accessible and proactive.”

-ENDS-

About M42

M42 is a first-of-its-kind, global tech-enabled health powerhouse committed to the sustainable future of health. The Abu Dhabi-headquartered company is transforming lives through innovative solutions that are solving the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is delivering the highest level of personalized, precise, and preventative health solutions to impactfully disrupt the global health landscape.

M42 has over 20,000 employees and more than 450 facilities in 26 countries. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 combines leading health technologies with state-of-the-art healthcare facilities to deliver world-class health solutions, services and care.

The M42 group includes Diaverum, Cleveland Clinic Abu Dhabi, Imperial College London Diabetes Centre and Moorfields Eye Hospital Abu Dhabi, among others.